Advanced Medical Solutions Group’s (AMS) “Hold” Rating Reiterated at Deutsche Bank Aktiengesellschaft

by · The Cerbat Gem

Advanced Medical Solutions Group (LON:AMS – Get Free Report)‘s stock had its “hold” rating reissued by Deutsche Bank Aktiengesellschaft in a report issued on Friday,Digital Look reports. They currently have a GBX 275 price objective on the stock. Deutsche Bank Aktiengesellschaft’s target price would indicate a potential downside of 1.43% from the stock’s previous close.

Several other research firms have also commented on AMS. Royal Bank Of Canada restated a “sector perform” rating and issued a GBX 260 price objective on shares of Advanced Medical Solutions Group in a research note on Thursday, April 9th. Berenberg Bank reissued a “buy” rating and set a GBX 300 price target on shares of Advanced Medical Solutions Group in a report on Tuesday, May 19th. Two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 270.25.

View Our Latest Stock Report on Advanced Medical Solutions Group

Advanced Medical Solutions Group Stock Performance

Shares of Advanced Medical Solutions Group stock traded up GBX 0.50 during trading hours on Friday, reaching GBX 279. 130,497,250 shares of the stock traded hands, compared to its average volume of 3,990,257. Advanced Medical Solutions Group has a one year low of GBX 187 and a one year high of GBX 279.50. The firm has a market capitalization of £606.07 million, a price-to-earnings ratio of 61.73, a P/E/G ratio of 5.00 and a beta of 0.71. The company has a quick ratio of 4.58, a current ratio of 2.79 and a debt-to-equity ratio of 31.50. The company has a 50 day moving average price of GBX 232.88 and a 200 day moving average price of GBX 218.23.

Advanced Medical Solutions Group Company Profile

(Get Free Report)

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.

Read More